Open Access Article
This Open Access Article is licensed under a Creative Commons Attribution 3.0 Unported Licence
Correction: A study towards drug discovery for the management of type 2 diabetes mellitus through inhibition of the carbohydrate-hydrolyzing enzymes α-amylase and α-glucosidase by chalcone derivatives
Sónia
Rocha
a,
Adelaide
Sousa
a,
Daniela
Ribeiro
a,
Catarina M.
Correia
b,
Vera L. M.
Silva
b,
Clementina M. M.
Santos
bc,
Artur M. S.
Silva
b,
Alberto N.
Araújo
a,
Eduarda
Fernandes
a and
Marisa
Freitas
*a
aLAQV, REQUIMTE, Laboratory of Applied Chemistry, Department of Chemical Sciences, Faculty of Pharmacy, University of Porto, 4050-313 Porto, Portugal. E-mail: marisafreitas@ff.up.pt
bQOPNA & LAQV-REQUIMTE, Department of Chemistry, University of Aveiro, Aveiro, Portugal
cCentro de Investigação de Montanha (CIMO) Instituto Politécnico de Bragança, Campus de Santa Apolónia, 5300-253 Bragança, Portugal
First published on 27th August 2019
Abstract
Correction for ‘A study towards drug discovery for the management of type 2 diabetes mellitus through inhibition of the carbohydrate-hydrolyzing enzymes α-amylase and α-glucosidase by chalcone derivatives’ by Sónia Rocha, et al., Food Funct., 2019, DOI: 10.1039/c9fo01298b.
The authors regret that some of the funding information included in the acknowledgements of the original article was incorrect. The first sentence in the acknowledgements should read as follows: “This work received financial support from the European Union and National Funds (FCT/MEC, Fundação para a Ciência e Tecnologia and Ministério da Educação e Ciência) under the Partnership Agreement PT2020 UID/QUI/50006/2019”, and “Programa Operacional Competitividade e Internacionalização” (COMPETE) (POCI-01-0145-FEDER-029241).
The Royal Society of Chemistry apologises for these errors and any consequent inconvenience to authors and readers.
| This journal is © The Royal Society of Chemistry 2019 |